Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Introduction to R01:11

Introduction to R

5.0K
R is a powerful software environment for statistical computing and graphics. Originating as an implementation of the S language, developed at Bell Laboratories, R has evolved into a robust, open-source statistical software favored by statisticians and data scientists worldwide. Its comprehensive suite includes data manipulation, calculation, and graphical display capabilities, making it versatile for data analysis and visualization. Its programming language is at the core of R's...
5.0K
Introduction to force01:25

Introduction to force

1.2K
Consider water flowing from a nozzle to a turbine vane. As the water hits the turbine vane, it exerts a force that causes it to move along the flow of direction. Force is an impact that changes an object's motion, shape, or orientation. Forces can be caused by physical contact, such as a push or pull, or through non-contact interactions, such as magnetic or gravitational forces. Force is a vector quantity with both magnitude and direction, and is measured in newtons (N) in the SI unit...
1.2K
Introduction to Urinary System01:13

Introduction to Urinary System

9.2K
The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
9.2K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

2.2K
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
2.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

908
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
908
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

2.5K
The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
2.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament Analyses.

Muscle & nerve·2026
Same author

Study 19 (MCI186-19) Post Hoc Analyses.

Muscle & nerve·2026
Same author

Safety of Intravenous Edaravone in Clinical Practice.

Muscle & nerve·2026
Same author

Generalizability of Edaravone Efficacy.

Muscle & nerve·2026
Same author

Current and Ongoing Clinical Studies.

Muscle & nerve·2026
Same author

Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral Sclerosis.

Muscle & nerve·2025
Same journal

At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial.

Muscle & nerve·2026
Same journal

The Use of the Four Square Step Test and the 10-m Walk/Run Test to Determine Fall Risk in Children With Duchenne Muscular Dystrophy.

Muscle & nerve·2026
Same journal

Administration of Schwann Cell-Like Cells Differentiated From Tonsil-Derived Mesenchymal Stem Cells Promotes Peripheral Nerve Regeneration by Inducing Macrophage Polarization in a Chronic Constriction Injury Model.

Muscle & nerve·2026
Same journal

Muscle Ultrasound Is a Sensitive Outcome Measure in ALS.

Muscle & nerve·2026
Same journal

The Impact of Sponsored Genetic Testing in 170 Consecutive Consenting Patients With Amyotrophic Lateral Sclerosis: A Single-Site Retrospective Review.

Muscle & nerve·2026
Same journal

Determinants of the Maximal Nerve Cross-Sectional Area and Its Role in the Separation of Entrapment and Compression Ulnar Neuropathies at the Elbow.

Muscle & nerve·2026
查看所有相关文章

相关实验视频

Updated: Feb 8, 2026

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

17.6K

附录的介绍 附录的介绍

Kelly G Gwathmey1, Stephen Apple2

  • 1Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.

Muscle & nerve
|February 7, 2026
PubMed
概括
此摘要是机器生成的。

爱达拉,一种治疗肌缩侧面硬化症 (ALS) 的药物,提供了一种新的口服悬浮配方. 这扩大了ALS患者的治疗选择,基于其静脉注射形式的已知好处.

关键词:
第19个研究骨髓缩侧面硬化症 (ALS) 是一种埃达拉沃尼是一个人有效性 有效性 有效性.在安全方面,安全是安全的.

更多相关视频

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.9K
Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
07:33

Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs

Published on: July 6, 2015

12.0K

相关实验视频

Last Updated: Feb 8, 2026

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

17.6K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.9K
Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
07:33

Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs

Published on: July 6, 2015

12.0K

科学领域:

  • 神经学 神经学
  • 药理学 药理学是指药理学的学科.
  • 临床研究 临床研究

背景情况:

  • 肌缩侧面硬化 (ALS) 是一种进展性神经肌肉疾病,患者表现不同.
  • 目前FDA批准的ALS治疗方法包括riluzole,edaravone (IV和口服),以及tofersen.
  • 埃达拉的疗效最初在日本患者中被证明 (研究19),导致IV配方获得批准.

研究的目的:

  • 提供数据,扩大人们对艾达拉在更广泛的ALS群体中的使用的理解.
  • 调查edaravone的安全性,疗效概括性,临床结果和健康经济学.
  • 告知临床医生,研究人员和利益相关者关于ALS管理中edaravone的不断变化的证据.

主要方法:

  • 从临床试验,后期分析和临床研究中获得的数据的审查.
  • 专注于临床实践中的安全性和疗效的概括性.
  • 包括健康经济学和结果研究.

主要成果:

  • 埃达拉口服悬浮体表现出良好的耐受性,与IV埃达拉相一致的安全性.
  • 该补充提供了数据,扩大了ALS中埃达拉的证据基础.
  • 调查结果包括安全性,疗效,临床结果和健康经济学.

结论:

  • 埃达拉,无论是静脉注射还是口服形式,都是对ALS的重要治疗选择.
  • 进一步的研究和数据分析继续完善对埃达拉在ALS中的作用的理解.
  • 提交的数据支持对ALS患者管理的决策.